Mesoblast (MESO) Tax Provisions (2016 - 2022)
Mesoblast's (MESO) quarterly Tax Provisions came in at $71000.0 in Q4 2022, down 11.25% year-on-year from $80000.0 in Q4 2021, and down 78.35% quarter-over-quarter from $328000.0 in Q2 2022.
Mesoblast (MESO) Tax Provisions (2016 - 2022) Analysis & Trends
Mesoblast has disclosed Tax Provisions across 7 years of filings, most recently posting $71000.0 for Q4 2022.
- Tax Provisions for Q4 2022 came in at $71000.0, down 11.25% year-over-year; the trailing twelve-month figure through Dec 2022 was $426000.0 (up 131.96% YoY), and the FY2025 annual result was $330000.0, up 272.77% from the prior year.
- Tax Provisions came in at $71000.0 for Q4 2022 at Mesoblast, down from $328000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $3.4 million in Q1 2018 to a low of -$15.6 million in Q2 2020.
- The 5-year median for Tax Provisions is $519500.0 (2018), against an average of $95833.3.
- Across the five-year window, Tax Provisions jumped 211.17% in 2019 and tumbled 590.18% in 2020, its largest moves.
- Mesoblast's Tax Provisions stood at $2.9 million in 2018, then declined by 20.8% to $2.3 million in 2019, then tumbled by 103.26% to -$74000.0 in 2020, then soared by 208.11% to $80000.0 in 2021, then slipped by 11.25% to $71000.0 in 2022.
- The last three Tax Provisions figures came in at $71000.0 (Q4 2022), $328000.0 (Q2 2022), and -$53000.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 71,000.00 |
| Jun 30, 2022 | 328,000.00 |
| Mar 31, 2022 | -53,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | -1.57 Mn |
| Mar 31, 2021 | 98,000.00 |
| Dec 31, 2020 | -74,000.00 |
| Sep 30, 2020 | 730,000.00 |
| Jun 30, 2020 | -15.57 Mn |
| Mar 31, 2020 | 1.96 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Jun 30, 2019 | 3.18 Mn |
| Mar 31, 2019 | 2.21 Mn |
| Dec 31, 2018 | 2.87 Mn |
| Sep 30, 2018 | 711,000.00 |
| Jun 30, 2018 | 1.02 Mn |
| Mar 31, 2018 | 3.43 Mn |
| Dec 31, 2017 | 23.34 Mn |
| Sep 30, 2017 | 2.90 Mn |